Approval · Notice of Compliance 15245 · 2014
ZALTRAP: Notice of Compliance 15245
Issued February 12, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15245
- Date
- February 12, 2014
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic agent
Products in this notice
Medicinal ingredients
- AFLIBERCEPT 100 MG per 4ML
- AFLIBERCEPT 200 MG per 8ML